Candida in IBD: Friend or Foe?

Julia Fritsch; Maria T. Abreu

doi:10.1016/j.chom.2020.04.018

Candida in IBD: Friend or Foe?

Julia Fritsch
, Maria T. Abreu

Research output: Contribution to journal › Comment/debate

5 Scopus citations

Abstract

In this issue of Cell Host & Microbe, Leonardi et al. demonstrate ulcerative colitis patients with high Candida responded best to fecal microbial transplant (FMT). However, decreased Candida post-treatment was associated with improved disease—suggesting that Candida reductions are associated with less inflammation. Pre-FMT Candida levels may identify FMT responders.

Original language	English
Pages (from-to)	689-691
Number of pages	3
Journal	Cell Host and Microbe
Volume	27
Issue number	5
DOIs	https://doi.org/10.1016/j.chom.2020.04.018
State	Published - 13 May 2020
Externally published	Yes

Access to Document

10.1016/j.chom.2020.04.018

Cite this

@article{aacd0a030a924e999641a821ebb566b0,

title = "Candida in IBD: Friend or Foe?",

abstract = "In this issue of Cell Host \& Microbe, Leonardi et al. demonstrate ulcerative colitis patients with high Candida responded best to fecal microbial transplant (FMT). However, decreased Candida post-treatment was associated with improved disease—suggesting that Candida reductions are associated with less inflammation. Pre-FMT Candida levels may identify FMT responders.",

author = "Julia Fritsch and Abreu, \{Maria T.\}",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Inc.",

year = "2020",

month = may,

day = "13",

doi = "10.1016/j.chom.2020.04.018",

language = "English",

volume = "27",

pages = "689--691",

journal = "Cell Host and Microbe",

issn = "1931-3128",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - Candida in IBD

T2 - Friend or Foe?

AU - Fritsch, Julia

AU - Abreu, Maria T.

PY - 2020/5/13

Y1 - 2020/5/13

N2 - In this issue of Cell Host & Microbe, Leonardi et al. demonstrate ulcerative colitis patients with high Candida responded best to fecal microbial transplant (FMT). However, decreased Candida post-treatment was associated with improved disease—suggesting that Candida reductions are associated with less inflammation. Pre-FMT Candida levels may identify FMT responders.

AB - In this issue of Cell Host & Microbe, Leonardi et al. demonstrate ulcerative colitis patients with high Candida responded best to fecal microbial transplant (FMT). However, decreased Candida post-treatment was associated with improved disease—suggesting that Candida reductions are associated with less inflammation. Pre-FMT Candida levels may identify FMT responders.

UR - https://www.scopus.com/pages/publications/85084254648

U2 - 10.1016/j.chom.2020.04.018

DO - 10.1016/j.chom.2020.04.018

M3 - Comment/debate

C2 - 32407705

AN - SCOPUS:85084254648

SN - 1931-3128

VL - 27

SP - 689

EP - 691

JO - Cell Host and Microbe

JF - Cell Host and Microbe

IS - 5

ER -

Candida in IBD: Friend or Foe?

Abstract

Access to Document

Fingerprint

Cite this